AbbVie (NYSE: ABBV) reported Q4 EPS of $1.20, $0.01 better than the analyst estimate of $1.19. Revenue for the quarter came in at $6.78 billion versus the consensus estimate of $6.92 billion.

For earnings history and earnings-related data on AbbVie (ABBV) click here.